Lantheus Holdings (LNTH) Consolidated Net Income (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Consolidated Net Income came in at $118.4 million in Q1 2026, up 62.34% year-on-year from $72.9 million in Q1 2025, and down 16.68% on a QoQ basis from $142.1 million in Q4 2025.

Lantheus Holdings (LNTH) Consolidated Net Income (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Consolidated Net Income data on file, last reported at $118.4 million in Q1 2026.

  • On a quarterly basis, Consolidated Net Income rose 62.34% year-over-year to $118.4 million in Q1 2026; TTM through Mar 2026 was $367.1 million, a 566.01% increase from a year earlier, with the FY2025 full-year figure at $321.6 million, up 1657.63% from the prior year.
  • Consolidated Net Income for Q1 2026 stood at $118.4 million, down from $142.1 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for LNTH reached as high as $142.1 million in Q4 2025 and fell as low as -$344.9 million in Q4 2024.
  • Historically, Consolidated Net Income has averaged $45.4 million across 5 years, with a median of $72.9 million in 2025.
  • On a YoY basis, Consolidated Net Income climbed as much as 4769.26% in 2024 and fell as far as 440.24% in 2024.
  • Year by year, Consolidated Net Income stood at -$119.2 million in 2022, then surged by 185.05% to $101.4 million in 2023, then tumbled by 440.24% to -$344.9 million in 2024, then soared by 141.21% to $142.1 million in 2025, then declined by 16.68% to $118.4 million in 2026.
  • Per Business Quant data, the three most recent Consolidated Net Income figures were $118.4 million in Q1 2026, $142.1 million in Q4 2025, and $27.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 370.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -3.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 274.90 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn 118.42 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 118.42 Mn
Dec 31, 2025 142.12 Mn
Sep 30, 2025 27.77 Mn
Jun 30, 2025 78.76 Mn
Mar 31, 2025 72.95 Mn
Dec 31, 2024 -344.88 Mn
Sep 30, 2024 131.09 Mn
Jun 30, 2024 62.07 Mn
Mar 31, 2024 131.07 Mn
Dec 31, 2023 101.36 Mn
Sep 30, 2023 131.96 Mn
Jun 30, 2023 94.13 Mn
Mar 31, 2023 -2.81 Mn
Dec 31, 2022 -119.19 Mn
Sep 30, 2022 61.23 Mn
Jun 30, 2022 43.06 Mn
Mar 31, 2022 42.96 Mn
Dec 31, 2021 -40.22 Mn
Sep 30, 2021 -13.42 Mn
Jun 30, 2021 -26.66 Mn